BENEFIT OF PROLONGED FILGOTINIB DOSING IN PATIENTS WITH ULCERATIVE COLITIS WHO DID NOT RESPOND TO INDUCTION THERAPY: DATA FROM THE SELECTION LONG-TERM EXTENSION STUDY
Severine Vermeire 1
Toshifumi Hibi 2
Alessandra Oortwijn 3
Simon Hatch 4
Silvio Danese 5
Brian G. Feagan 6
William Sandborn 7
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
2 Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
3 Galapagos NV, Leiden, Netherlands
4 Galapagos Inc., Waltham, MA, United States
5 IBD Center, Humanitas Research Hospital, Milan, Italy
6 Robarts Research Institute, Western University, London, ON, Canada
7 University of California San Diego, La Jolla, CA, United States
Session
IBD: Clinical trials poster II
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]